Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb:62:244.e1-244.e8.
doi: 10.1016/j.neurobiolaging.2017.09.035. Epub 2017 Oct 10.

Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease

Collaborators, Affiliations

Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease

Sultan Chaudhury et al. Neurobiol Aging. 2018 Feb.

Abstract

Sporadic early-onset Alzheimer's disease (sEOAD) exhibits the symptoms of late-onset Alzheimer's disease but lacks the familial aspect of the early-onset familial form. The genetics of Alzheimer's disease (AD) identifies APOEε4 to be the greatest risk factor; however, it is a complex disease involving both environmental risk factors and multiple genetic loci. Polygenic risk scores (PRSs) accumulate the total risk of a phenotype in an individual based on variants present in their genome. We determined whether sEOAD cases had a higher PRS compared to controls. A cohort of sEOAD cases was genotyped on the NeuroX array, and PRSs were generated using PRSice. The target data set consisted of 408 sEOAD cases and 436 controls. The base data set was collated by the International Genomics of Alzheimer's Project consortium, with association data from 17,008 late-onset Alzheimer's disease cases and 37,154 controls, which can be used for identifying sEOAD cases due to having shared phenotype. PRSs were generated using all common single nucleotide polymorphisms between the base and target data set, PRS were also generated using only single nucleotide polymorphisms within a 500 kb region surrounding the APOE gene. Sex and number of APOE ε2 or ε4 alleles were used as variables for logistic regression and combined with PRS. The results show that PRS is higher on average in sEOAD cases than controls, although there is still overlap among the whole cohort. Predictive ability of identifying cases and controls using PRSice was calculated with 72.9% accuracy, greater than the APOE locus alone (65.2%). Predictive ability was further improved with logistic regression, identifying cases and controls with 75.5% accuracy.

Keywords: Genotyping; NeuroChip; NeuroX; Polygenic risk score (PRS); Sporadic early-onset Alzheimer's disease (sEOAD).

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

The authors have no actual or potential conflicts of interest.

Figures

Fig. 1
Fig. 1
Proportion of diagnosed sEOAD cases and controls at each decile determined by a range of score. The figure breaks down the range of PRS into deciles. The range of scores which make up each decile are depicted, as well as the number of cases and controls, and the percentage of individuals which fall into each decile. Controls are right skewed, whereas cases demonstrate left skewness. These figures were produced from PRS of 408 sEOAD cases and 436 controls. The embedded table lists the decile ranges with the number of cases and controls in each decile along with the proportion of the cohort which make up each decile. Abbreviations: PRS, polygenic risk score; sEOAD, sporadic early-onset Alzheimer’s disease.
Fig. 2
Fig. 2
Distribution of polygenic risk score among sEOAD cases and controls with average scores at each decile. The range of PRS obtained for cases and controls is distributed into deciles. The range of coverage of each decile is shown in the bar plot together with the proportion of cases and controls which make up each decile. The average scores for all cases and controls are indicated by the thick bar, while the short horizontal bars show PRS for each individual. Average scores at each decile are indicated as hollow circles for cases and filled circles for controls. Abbreviations: PRS, polygenic risk score; sEOAD, sporadic early-onset Alzheimer’s disease.
Fig. 3
Fig. 3
Results of logistic regression with an area under the receiver operating characteristic curve (AUC) for alternative risk-scoring models in sEOAD. For this analysis, the APOE locus was defined as a 500 kb region surrounding the APOE gene, and the scores produced by PRSice for this model are based on the SNPs within that region; PRS represents the score produced for all SNPs present on both the NeuroX array and in the base data set. The relevant variables included sex together with the number of APOE ε2 allele and/or APOE ε4 allele. As shown in the table, a nonsignificant Hosmer-Lemeshow p-value suggests that the model is suitable for using as a predictive tool. Nagelkerke’s R2 can also be used to identify the best model for risk prediction; the higher the value of R2 the greater the predictive accuracy of each model. This approach identified sex, ε2, ε4 + PRS as the best model for calculating risk in our sEOAD cohort as the largest AUC value is produced from the combination of variables. Abbreviations: PRS, polygenic risk score; sEOAD, sporadic early-onset Alzheimer’s disease; SNPs, single nucleotide polymorphisms.

Similar articles

Cited by

References

    1. Adams HH, de Bruijn RF, Hofman A, Uitterlinden AG, van Duijn CM, Vernooij MW, Koudstaal PJ, Ikram MA. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia. Alzheimers Dement. 2015;11:1277–1285. - PubMed
    1. Ayers KL, Mirshahi UL, Wardeh AH, Murray MF, Hao K, Glicksberg BS, Li S, Carey DJ, Chen R. A loss of function variant in CASP7 protects against Alzheimer’s disease in homozygous APOE ε4 allele carriers. BMC Genomics. 2016;17:445. - PMC - PubMed
    1. Barber I, Braae A, Clement N, Patel T, Guetta-Baranes T, Brookes K, Medway C, Chappell S, Guerreiro R, Bras J, Hernandez D, Singleton A, Hardy J, Mann D, ARUK Consortium. Morgan K. Mutational analysis of sporadic early-onset Alzheimer’s disease using the NeuroX array. Neurobiol. Aging. 2017;49:215.e1–215.e8. - PMC - PubMed
    1. Basu S, Pan W, Shen X, Oetting WS. Multilocus association testing with penalized regression. Genet. Epidemiol. 2011;35:755–765. - PMC - PubMed
    1. Blauwendraat C, Faghri F, Pihlstrom L, Geiger JT, Elbaz A, Lesage S, Corvol J, May P, Ryten M, Ferrari R, Bras J, Guerreiro R, Williams J, Sims R, Lubbe S, Hernandez DG, Mok KY, Robak L, Campbell RH, Rogaeva E, Traynor BJ, Chia R, Chung SJ, International Parkinson’s Disease Genomics Consortium (IPDGC) COURAGE-PD Consortium. Hardy JA, Brice A, Wood NW, Houlden H, Shulman JM, Morris HR, Gasser T, Krüger R, Heutink P, Sharma M, Simón Sánchez J, Nalls MA, Singleton AB, Scholz SW. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases. Neurobiol. Aging. 2017;57:247.e9–247.e13. - PMC - PubMed

Publication types